Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mohamed Hassan Sayegh, M.D.

Co-Author

This page shows the publications co-authored by Mohamed Sayegh and Reza Abdi.
Connection Strength

2.243
  1. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes. 2008 Jul; 57(7):1759-67.
    View in: PubMed
    Score: 0.384
  2. The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection. Diabetes. 2002 Aug; 51(8):2489-95.
    View in: PubMed
    Score: 0.255
  3. The novel role of SERPINB9 in cytotoxic protection of human mesenchymal stem cells. J Immunol. 2011 Sep 01; 187(5):2252-60.
    View in: PubMed
    Score: 0.119
  4. Donor antioxidant strategy prolongs cardiac allograft survival by attenuating tissue dendritic cell immunogenicity(†). Am J Transplant. 2011 Feb; 11(2):348-55.
    View in: PubMed
    Score: 0.114
  5. Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1. J Immunol. 2011 Jan 01; 186(1):121-31.
    View in: PubMed
    Score: 0.114
  6. Mesenchymal stem cells express serine protease inhibitor to evade the host immune response. Blood. 2011 Jan 27; 117(4):1176-83.
    View in: PubMed
    Score: 0.113
  7. Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes. Diabetes. 2010 Dec; 59(12):3139-47.
    View in: PubMed
    Score: 0.112
  8. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol. 2009 Jul 15; 183(2):993-1004.
    View in: PubMed
    Score: 0.103
  9. Targeting CD22 reprograms B-cells and reverses autoimmune diabetes. Diabetes. 2008 Nov; 57(11):3013-24.
    View in: PubMed
    Score: 0.097
  10. Phenotypic and functional differences between wild-type and CCR2-/- dendritic cells: implications for islet transplantation. Transplantation. 2008 Apr 15; 85(7):1030-8.
    View in: PubMed
    Score: 0.095
  11. Beta 3 integrins regulate lymphocyte migration and cytokine responses in heart transplant rejection. Am J Transplant. 2007 May; 7(5):1080-90.
    View in: PubMed
    Score: 0.088
  12. Characterization of donor dendritic cells and enhancement of dendritic cell efflux with CC-chemokine ligand 21: a novel strategy to prolong islet allograft survival. Diabetes. 2007 Apr; 56(4):912-20.
    View in: PubMed
    Score: 0.087
  13. Role of CXC chemokine receptor 3 pathway in renal ischemic injury. J Am Soc Nephrol. 2006 Mar; 17(3):716-23.
    View in: PubMed
    Score: 0.081
  14. Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo. J Immunol. 2004 Jan 15; 172(2):767-75.
    View in: PubMed
    Score: 0.070
  15. Allorecognition and effector pathways of islet allograft rejection in normal versus nonobese diabetic mice. J Am Soc Nephrol. 2003 Aug; 14(8):2168-75.
    View in: PubMed
    Score: 0.068
  16. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade. Diabetes. 2002 Nov; 51(11):3202-10.
    View in: PubMed
    Score: 0.065
  17. P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes. J Clin Invest. 2018 08 01; 128(8):3490-3503.
    View in: PubMed
    Score: 0.048
  18. Live Images of Donor Dendritic Cells Trafficking via CX3CR1 Pathway. Front Immunol. 2016; 7:412.
    View in: PubMed
    Score: 0.043
  19. ABCB5 Identifies Immunoregulatory Dermal Cells. Cell Rep. 2015 Sep 08; 12(10):1564-74.
    View in: PubMed
    Score: 0.039
  20. Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens. Diabetes. 2015 Jan; 64(1):158-71.
    View in: PubMed
    Score: 0.037
  21. Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7. Circulation. 2013 Jan 29; 127(4):463-75.
    View in: PubMed
    Score: 0.033
  22. Role of nuclear factor of activated T cell (NFAT) transcription factors in skin and vascularized cardiac allograft rejection. Transplantation. 2011 Sep 15; 92(5):e26-7.
    View in: PubMed
    Score: 0.030
  23. A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice. Diabetes. 2010 Sep; 59(9):2253-64.
    View in: PubMed
    Score: 0.028
  24. A novel alloantigen-specific CD8+PD1+ regulatory T cell induced by ICOS-B7h blockade in vivo. J Immunol. 2007 Jul 15; 179(2):786-96.
    View in: PubMed
    Score: 0.022
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.